Our data demonstrate for the first time that NDRG2 inhibits glycolysis in colorectal cancer cells by inhibiting glucose transporter 1, catalytic enzymes HK2, PKM2, LDHA. The gene discussed is LDHA; the disease is colorectal cancer.